Premaquick Biomarkers versus Transvaginal Ultrasonographically Measured Cervical Length for Pre-Induction Cervical Assessment at Term: A Double Blind Randomized Study
Not Applicable
Recruiting
- Conditions
- pregnancy and delivery
- Registration Number
- PACTR202001579275333
- Lead Sponsor
- DR CHIGOZIE OKAFOR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 72
Inclusion Criteria
1. Term (37-42weeks) singleton pregnancy
2. Primigravida or Nulliparous pregnant women
3. Cephalic presenting fetus
4. Presence of intact fetal membranes
5. No contraindications to vaginal delivery
Exclusion Criteria
1. Preterm pregnancy
2. Intra uterine fetal death
3. Cephalopelvic disproportion
4. Fetal abnormal lie
5. Fetal abnormal presentation
6. Multiple pregnancy
7. Previous caeserean scar or uterine surgeries
8. Preinduction fetal heart rate abnormalities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Proportion of women who will need prostaglandin analogue for cervical ripening after preinduction cervical assessment by each method;2. Proportion of women who will achieve vaginal delivery after induction of labour in each group
- Secondary Outcome Measures
Name Time Method 1. Mean induction to delivery interval in hours after induction of labour in each group;2. The proportion of women who will be delivered by caesarean section after induction of labour in each group;3. Mean total dose of prostaglandins administered for preinduction cervical ripening in each group;4. Proportion of neonates with birth asphyxia with APGAR score less than 6 in 1st minute in each group;5. Proportion of neonates that will require admission into the New born special care baby unit in each group